Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

IntriCon second-quarter net sales increase 16.6% to $14.9 million

IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical devices, today announced financial results for its second quarter ended June 30, 2010.

28 Jul 2010

GE Healthcare completes new $15 million medical technology manufacturing facility in Cardiff, Wales

Life sciences giant GE Healthcare has opened a $15 million medical technology manufacturing facility in Cardiff, Wales. The new facility is based at the 30-acre Maynard Centre, where the company already employs over 400 people.

28 Jul 2010

InterMune second-quarter total revenue decreases to $5.9 million

InterMune, Inc. today announced results from operations for the second quarter and six months ended June 30, 2010. InterMune also highlighted its recent clinical development and business activities, and provided forward-looking financial guidance for 2010.

28 Jul 2010

Growth in dental implant sales to propel bone-graft-substitute market

According to new dental reports by iData Research, the leading global authority in medical device, dental and pharmaceutical market research, the U.S. market for dental implants is expected to regain double-digit growth by 2013, and will help drive the dental prosthetic market to reach over 82 million prosthetic placements by 2016.

27 Jul 2010

Encision reports 8% decline in first-quarter fiscal 2011 net sales

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported its financial results for its first fiscal quarter ended June 30, 2010.

27 Jul 2010

Psychologists to host China's first-ever conference on positive psychology

The ranks of China's millionaires continue to grow, but the increased wealth has done little to boost the country's gross domestic happiness, according to psychologists at the University of California, Berkeley. They say the pursuit of prosperity in the nation is fast outpacing mental health and well-being, and are seeking to correct that imbalance by spreading the science of happiness in China.

27 Jul 2010

Zetiq reports self declaration CE mark of conformity for cervical cancer diagnostic kit

Zetiq Technologies Ltd., a subsidiary of Bio-Light Ltd., reports that it has fulfilled the essential requirements towards issuing a self declaration CE mark of conformity for its diagnostic product for identification of cervical cancer in cytological specimens.

27 Jul 2010

ProtAffin signs manufacturing contract with CMC Biologics for COPD drug PA401

ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today announced it has signed a manufacturing contract with CMC Biologics' Danish operations, located in Copenhagen, Denmark for manufacture of its lead product PA401 for the treatment of chronic obstructive pulmonary disease (COPD). The contract will cover manufacture and supply of PA401 for preclinical development and early clinical development in COPD and related respiratory indications.

27 Jul 2010

Novartis launches new OTC children's liquid acetaminophen product

Novartis announces the introduction of Triaminic™ Fever Reducer Pain Reliever, the only branded over-the-counter children's liquid acetaminophen product currently available nationwide in the US. Triaminic® now offers parents a product that combines the pain relieving and fever-reducing power of acetaminophen with the brand that has been trusted by pediatricians and parents for more than 50 years.

27 Jul 2010

Quidel recommences shipments of QuickVue+ lateral flow diagnostic test for infectious mononucleosis

Quidel Corporation, a leading provider of rapid diagnostic testing solutions, announced today that it has begun taking orders for its QuickVue®+ lateral flow diagnostic test for infectious mononucleosis. Due to strong customer demand, the Company has restarted manufacturing its previous mononucleosis product with shipments to customers expected during the first week of August.

27 Jul 2010

Alexza second-quarter net loss decreases to $12.9 million

Alexza Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2010 and provided a business update. The net loss for the three and six months ended June 30, 2010, as reported in accordance with accounting principles generally accepted in the United States (GAAP), was $12.9 million and $26.3 million, respectively, compared to a net loss of $17.0 million and $23.9 million in the respective comparable periods in 2009. Alexza had consolidated cash, cash equivalents and marketable securities at June 30, 2010 of $41.7 million.

27 Jul 2010

Analogic Medical Equipment receives ISO 13485 certification and ships first MRI amplifier product

Analogic Corporation, a leading provider of medical imaging and aviation security technology, announced today that the Company's newly established China operations, Analogic Medical Equipment (Shanghai) Co., Ltd., has received ISO 13485 certification and shipped its first MRI amplifier product.

26 Jul 2010

Harco announces contract to manufacture MediGLIDER products for ConMediSys

Harco Metal Products (Harco), an industry leader in tube fabrication, systems integration, and seamless, cost effective manufacturing, announced today the contract to manufacture MediGLIDER™ products for ConMediSys.

26 Jul 2010

Experts available for comment on new medicare contracts that drive health care hookups

So-called "accountable care organizations" or ACOs might change the way that the agency running Medicare does business. An article in the Indiana Business Journal explains that the new health reform law requires the agency to sign new "shared savings" contracts with ACOs and gives examples of how these organizations work. ACOs can begin doing business with Medicare in January 2012.

26 Jul 2010

Axela acquires Xceed Molecular

Axela Inc., an innovator in systems that multiplex protein biomarker testing in clinical research and diagnostics, has acquired Xceed Molecular, developer of the award-winning Ziplex® System for gene-expression analysis, the Breast Cancer Prognostic Assay, and Colon Cancer Xpress chip. The new Axela will be introduced at the 2010 American Association of Clinical Chemistry (AACC) annual meeting and Clinical Lab Expo, which takes place July 25 – 29 at the Anaheim Convention Center in California.

26 Jul 2010

Cerenis, Novasep awarded French Government funding for development of CER-001 HDL mimetic

Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and other metabolic diseases, and Groupe Novasep (Novasep), a leading supplier of manufacturing solutions to the life sciences industries, announce today that they have received French Government funding through OSEO to finance the development of CER-001, a Cerenis HDL mimetic.

26 Jul 2010

Novartis, Nordic Bioscience to continue oral calcitonin Phase III study in osteoarthritis patients

Unigene Laboratories, Inc. announced today that Novartis and its license partner Nordic Bioscience have decided to continue the companies' two-year, Phase III Study 2302 assessing safety and efficacy of oral calcitonin in patients with osteoarthritis of the knee. Novartis has a worldwide license to produce recombinant calcitonin under Unigene's patented SecraPep® E. coli manufacturing technology.

23 Jul 2010

IDEXX Laboratories second-quarter 2010 revenues increase 6% to $281.5 million

IDEXX Laboratories, Inc., today reported that revenues for the second quarter of 2010 increased 6% to $281.5 million, from $265.7 million for the second quarter of 2009. Organic revenue growth, as defined below, was 5%. Earnings per diluted share for the quarter ended June 30, 2010 increased 13% to $0.62, compared to $0.55 for the same period in the prior year.

23 Jul 2010

Fresenius Medical Care, Nikkiso enter 10-year exclusive distribution agreement for dialysis products in Japan

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, has entered into a long-term, 10-year exclusive distribution agreement with Japanese-based Nikkiso Co. Ltd. for hemodialysis and peritoneal dialysis products in Japan.

23 Jul 2010

MiMedx Group reports revenues of $322,000 for second-quarter 2010

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today its results for the second quarter ended June 30, 2010.

23 Jul 2010

Manufacturing News and Research

Further Reading

IntriCon second-quarter net sales increase 16.6% to $14.9 million

GE Healthcare completes new $15 million medical technology manufacturing facility in Cardiff, Wales

InterMune second-quarter total revenue decreases to $5.9 million

Growth in dental implant sales to propel bone-graft-substitute market

Encision reports 8% decline in first-quarter fiscal 2011 net sales

Psychologists to host China's first-ever conference on positive psychology

Zetiq reports self declaration CE mark of conformity for cervical cancer diagnostic kit

ProtAffin signs manufacturing contract with CMC Biologics for COPD drug PA401

Novartis launches new OTC children's liquid acetaminophen product

Quidel recommences shipments of QuickVue+ lateral flow diagnostic test for infectious mononucleosis

Alexza second-quarter net loss decreases to $12.9 million

Analogic Medical Equipment receives ISO 13485 certification and ships first MRI amplifier product

Harco announces contract to manufacture MediGLIDER products for ConMediSys

Experts available for comment on new medicare contracts that drive health care hookups

Axela acquires Xceed Molecular

Cerenis, Novasep awarded French Government funding for development of CER-001 HDL mimetic

Novartis, Nordic Bioscience to continue oral calcitonin Phase III study in osteoarthritis patients

IDEXX Laboratories second-quarter 2010 revenues increase 6% to $281.5 million

Fresenius Medical Care, Nikkiso enter 10-year exclusive distribution agreement for dialysis products in Japan

MiMedx Group reports revenues of $322,000 for second-quarter 2010

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy